ENTA logo

Enanta Pharmaceuticals (ENTA) Total Debt

Annual Total Debt

$26.51 M
+$1.25 M+4.95%

30 September 2023

ENTA Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$50.57 M
+$3.57 M+7.61%

30 June 2024

ENTA Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTA Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+90.7%
3 y3 years+397.5%+848.9%
5 y5 years+10000.0%+10000.0%

ENTA Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+397.5%at high+848.9%
5 y5 yearsat high>+9999.0%at high>+9999.0%
alltimeall timeat highat high

Enanta Pharmaceuticals Total Debt History

DateAnnualQuarterly
June 2024
-
$50.57 M(+7.6%)
Mar 2024
-
$46.99 M(+84.4%)
Dec 2023
-
$25.49 M(-3.9%)
Sept 2023
$26.51 M(+4.9%)
$26.51 M(-4.3%)
June 2023
-
$27.70 M(-1.1%)
Mar 2023
-
$28.00 M(+10.5%)
Dec 2022
-
$25.34 M(+0.3%)
Sept 2022
$25.26 M(+374.1%)
$25.26 M(+1.8%)
June 2022
-
$24.81 M(+36.8%)
Mar 2022
-
$18.13 M(-6.7%)
Dec 2021
-
$19.43 M(+264.6%)
Sept 2021
$5.33 M(-34.2%)
$5.33 M(-20.1%)
June 2021
-
$6.67 M(-14.7%)
Mar 2021
-
$7.82 M(-10.3%)
Dec 2020
-
$8.72 M(+7.6%)
Sept 2020
$8.10 M(+3949.5%)
$8.10 M(-8.1%)
June 2020
-
$8.81 M(-3.1%)
Mar 2020
-
$9.09 M(-0.3%)
Dec 2019
-
$9.12 M(+4459.5%)
Sept 2019
$200.00 K(-31.7%)
$200.00 K(-10.7%)
June 2019
-
$224.00 K(-10.0%)
Mar 2019
-
$249.00 K(-8.1%)
Dec 2018
-
$271.00 K(-7.5%)
Sept 2018
$293.00 K
$293.00 K(-7.0%)
June 2018
-
$315.00 K(-6.5%)
Mar 2018
-
$337.00 K(-5.9%)
DateAnnualQuarterly
Dec 2017
-
$358.00 K(-5.5%)
Sept 2017
$379.00 K(-28.6%)
$379.00 K(-20.5%)
June 2017
-
$477.00 K(-3.8%)
Mar 2017
-
$496.00 K(-3.7%)
Dec 2016
-
$515.00 K(-3.0%)
Sept 2016
$531.00 K(-11.2%)
$531.00 K(-3.3%)
June 2016
-
$549.00 K(-2.8%)
Mar 2016
-
$565.00 K(-2.9%)
Dec 2015
-
$582.00 K(-2.7%)
Sept 2015
$598.00 K(>+9900.0%)
$598.00 K(+241.7%)
June 2015
-
$175.00 K(>+9900.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
-
$0.00(0.0%)
Sept 2014
$0.00(0.0%)
$0.00(0.0%)
June 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
-
$0.00(0.0%)
Sept 2013
$0.00(0.0%)
$0.00(0.0%)
June 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
-
$0.00(0.0%)
Sept 2012
$0.00(0.0%)
$0.00(0.0%)
June 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
-
$0.00(0.0%)
Sept 2011
$0.00(0.0%)
$0.00
Sept 2010
$0.00
-

FAQ

  • What is Enanta Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly total debt year-on-year change?

What is Enanta Pharmaceuticals annual total debt?

The current annual total debt of ENTA is $26.51 M

What is the all time high annual total debt for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual total debt is $26.51 M

What is Enanta Pharmaceuticals quarterly total debt?

The current quarterly total debt of ENTA is $50.57 M

What is the all time high quarterly total debt for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly total debt is $50.57 M

What is Enanta Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, ENTA quarterly total debt has changed by +$24.05 M (+90.73%)